The CanScreen5 project is a global cancer screening data repository that aims to report the status and performance of breast, cervical and colorectal cancer screening programs using a harmonized set of criteria and indicators. Data collected mainly from the Ministry of Health in each country underwent quality validation and ultimately became publicly available through a Web-based portal. Until September 2022, 84 participating countries reported data for breast (n = 57), cervical (n = 75) or colorectal (n = 51) cancer screening programs in the repository. Substantial heterogeneity was observed regarding program organization and performance. Reported screening coverage ranged from 1.7% (Bangladesh) to 85.5% (England, United Kingdom) for breast cancer, from 2.1% (Côte d’Ivoire) to 86.3% (Sweden) for cervical cancer, and from 0.6% (Hungary) to 64.5% (the Netherlands) for colorectal cancer screening programs. Large variability was observed regarding compliance to further assessment of screening programs and detection rates reported for precancers and cancers. A concern is lack of data to estimate performance indicators across the screening continuum. This underscores the need for programs to incorporate quality assurance protocols supported by robust information systems. Program organization requires improvement in resource-limited settings, where screening is likely to be resource-stratified and tailored to country-specific situations.
Highlights Behavioral economic-based interventions have been suggested to increase uptake in CRC screening programmes. This study tested the effectiveness of six behavioral economic-based messages in two field trials. None of the messages increased screening participation.
Cyprus is under an Economic adjustment program. The Memorandum of Understanding (MOU) between Cyprus and Troika includes a number of reform measures, including structural and cost containing measures. The main reforms relate to the implementation of the NHS, as well as reforms relating to public hospitals and other health facilities. According to existing timeframes, the new National Health System (NHS) is expected to be fully in place by mid-2016, whereas various policy and implementation issues continue to be under careful study and investigation by the Ministry of Health.The needs of general practice doctors on rheumatologic education must be considered from within the context of their working environment. The population has free choice to visit either any specialist or a general practitioner. But still the GPs are usually the first port of call for most patients with symptoms of illness.Whereas the patients have free access to a general practitioner may present with illnesses which cross the boundaries of specialties such as rheumatology or orthopedic or with symptoms of problems that are best located within other health professionals (psychologist, physiotherapist etc). Consequently, there is a different set of priorities for investigation and management within general practice, which includes the early detection of the problem and the early reference to the suitable specialist.The Cyprus National Committee for Rheumatologist Diseases, having in mind the new conditions regarding the reform measures of the health system in Cyprus and the role of GPs in the environment of NHS took the initiative to prepare the general practitioner doctors in order to recognize the symptoms, to determine the diagnosis and to intervene in time for the best management and treatment of their patients. The Training courses include case studies, lectures and workshops. The main scope is GPs doctors come into contact and become familiar with the disease and promptly recognise the symptoms.Disclosure of InterestNone declared
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2025 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.